Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting primarily motor neurons. People with ALS experience spasticity, muscle weakness, muscle atrophy and weakness. And while there are some interventions to help improve the quality of life for those with ALS, there is currently no treatment that stops the progression of the disease.

Dr. Berry is an active clinical researcher with a strong commitment to collaborative research. His team designs, leads, and conducts multicenter studies and trials aimed at identifying new therapeutic targets, discovering novel ALS biomarkers and testing potential new therapeutics in people. He has collaborated with researchers studying patient-derived stem cells, RNA processing deficits, protein aberrations, immune system changes and other pathological mechanisms of ALS.